Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuroendocrine tumor that arises from the gastrointestinal tract and produces glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns.
Biomarker and diagnostic research for L-cell glucagon-like peptide-producing neuroendocrine tumor has been reported in the published literature.
No clinical trials have been registered for L-cell glucagon-like peptide-producing neuroendocrine tumor.
6 publications have been identified in PubMed for L-cell glucagon-like peptide-producing neuroendocrine tumor. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (33%), and Diagnostic / Biomarker (17%).
Kasajima A (2026). [PMID: 41483302](https://pubmed.ncbi.nlm.nih.gov/41483302/). *Virchows Arch*. [Review / Meta-Analysis]
Delfin L (2025). [PMID: 40553402](https://pubmed.ncbi.nlm.nih.gov/40553402/). *Endocr Pathol*. [Diagnostic / Biomarker]
Mete O (2024). [PMID: 38833137](https://pubmed.ncbi.nlm.nih.gov/38833137/). *Endocr Pathol*. [Case Report / Case Series]
Franchina M (2024). [PMID: 38928704](https://pubmed.ncbi.nlm.nih.gov/38928704/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Shende P (2024). [PMID: 39211694](https://pubmed.ncbi.nlm.nih.gov/39211694/). *Cureus*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:42 AM UTC
Common questions about L-cell glucagon-like peptide-producing neuroendocrine tumor